NACDS submitted the statement before Wednesday’s House Energy and Commerce Subcommittee on Oversight and Investigations and Senate Finance Committee hearings examining the impact of the Change Healthcare cyberattack.
The high-concentration interchangeable biosimilar to AbbVie Biotechnology's Humira manufactured by Alvotech will be distributed under Quallent’s private-label.